🔴 Johnson & Johnson is trading 3.13% down in pre-market following Q3 results

Johnson & Johnson is trading at $255.48, down 3.13% in pre-market following its Q3 earnings announcement.

• Before the October 13 open, adjusted EPS was $2.59; reported EPS was $0.09, reflecting a one-time charge tied partly to the proposed talc litigation resolution.
• Sales were $25.4 billion, up 5.9%, and full-year adjusted EPS guidance was raised to $11.10 at the midpoint.